Skip to main content
. 2020 May 13;20(2):1003–1011. doi: 10.3892/etm.2020.8743

Figure 2.

Figure 2

Effects of catalpol on DOX-induced effects in H9C2 cells. The Cell Counting Kit-8 assay was performed to assess H9C2 cell viability following treatment with various concentrations of (A) catalpol alone and (B) catalpol co-treatment with 1 µM DOX. (C) PPAR-γ protein expression levels were determined by western blotting. *P<0.05, **P<0.01 and ***P<0.001 vs. 0 µM or control; #P<0.01 and ###P<0.001 vs. Catalpol (0 µM) + DOX (1 µM). DOX, doxorubicin; PPAR-γ, peroxisome proliferator-activated receptor-γ.